TPSB2 (tryptase beta 2) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways
Gene: TPSB2 (tryptase beta 2) Homo sapiens
Analyze
Symbol: TPSB2
Name: tryptase beta 2
RGD ID: 1348891
HGNC Page HGNC:14120
Description: Predicted to enable heparin binding activity and serine-type endopeptidase activity. Predicted to be involved in proteolysis. Located in extracellular matrix.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: mast cell tryptase beta II; mast cell tryptase beta III; testicular tissue protein Li 163; TPS2; tryptase beta 2 (gene/pseudogene); tryptase beta II; tryptase beta III; tryptase beta-2; tryptase II; tryptase III; tryptase-2; tryptaseB; tryptaseC
RGD Orthologs
Mouse
Rat
Bonobo
Pig
Alliance Orthologs
More Info more info ...
Related Pseudogenes: TPSP2  
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
NCBI Annotation Information: Note: Genetic polymorphisms result in both protein coding and non-coding alleles of this gene.
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38161,228,336 - 1,230,184 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl161,227,272 - 1,233,725 (-)Ensemblhg38GRCh38
GRCh37161,278,336 - 1,280,185 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36161,218,337 - 1,220,186 (-)NCBIBuild 36Build 36hg18NCBI36
Build 34161,230,940 - 1,232,555NCBI
Celera161,494,229 - 1,494,587 (-)NCBICelera
Cytogenetic Map16p13.3NCBI
HuRef161,211,394 - 1,224,892 (-)NCBIHuRef
CHM1_1161,278,009 - 1,279,872 (-)NCBICHM1_1
T2T-CHM13v2.0161,243,646 - 1,245,495 (-)NCBIT2T-CHM13v2.0
JBrowse:




Disease Annotations     Click to see Annotation Detail View
Keloid  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
proteolysis  (IBA,IEA)

Cellular Component

Molecular Function

References

References - curated
# Reference Title Reference Citation
1. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
2. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:2187193   PMID:2203827   PMID:8434231   PMID:9521329   PMID:9920877   PMID:10391906   PMID:10500112   PMID:10708850   PMID:10843716   PMID:10898108   PMID:11157797   PMID:12217407  
PMID:12477932   PMID:14670919   PMID:15489334   PMID:15567416   PMID:17449330   PMID:17474147   PMID:19748655   PMID:20210993   PMID:21873635   PMID:22046132   PMID:24142694   PMID:27559042  
PMID:28514442   PMID:31337736   PMID:33961781   PMID:37511292  


Genomics

Comparative Map Data
TPSB2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38161,228,336 - 1,230,184 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl161,227,272 - 1,233,725 (-)Ensemblhg38GRCh38
GRCh37161,278,336 - 1,280,185 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36161,218,337 - 1,220,186 (-)NCBIBuild 36Build 36hg18NCBI36
Build 34161,230,940 - 1,232,555NCBI
Celera161,494,229 - 1,494,587 (-)NCBICelera
Cytogenetic Map16p13.3NCBI
HuRef161,211,394 - 1,224,892 (-)NCBIHuRef
CHM1_1161,278,009 - 1,279,872 (-)NCBICHM1_1
T2T-CHM13v2.0161,243,646 - 1,245,495 (-)NCBIT2T-CHM13v2.0
Tpsb2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391725,585,282 - 25,587,070 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1725,585,170 - 25,588,079 (+)EnsemblGRCm39 EnsemblGRCm39
GRCm381725,366,308 - 25,368,096 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1725,366,305 - 25,369,098 (+)Ensemblmm10GRCm38
MGSCv371725,503,278 - 25,505,037 (+)NCBIMGSCv37MGSCv37mm9NCBIm37
MGSCv361725,093,933 - 25,095,692 (+)NCBIMGSCv36mm8
Celera1725,894,349 - 25,896,108 (+)NCBICelera
Cytogenetic Map17A3.3NCBI
cM Map1712.53NCBI
Tpsb2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81014,886,310 - 14,888,102 (+)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl1014,886,360 - 14,888,100 (+)EnsemblGRCr8
mRatBN7.21014,381,779 - 14,383,571 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1014,382,013 - 14,383,569 (+)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx1019,122,492 - 19,124,284 (+)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01018,611,363 - 18,613,155 (+)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01014,110,546 - 14,112,338 (+)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.01014,722,672 - 14,724,464 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1014,722,756 - 14,724,600 (+)Ensemblrn6Rnor6.0
Rnor_5.01014,539,018 - 14,540,810 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41014,613,118 - 14,614,917 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1014,053,492 - 14,055,284 (+)NCBICelera
RGSC_v3.11014,613,117 - 14,614,917 (+)NCBI
Cytogenetic Map10q12NCBI
LOC100978423
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2181,484,128 - 1,485,978 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1165,264,473 - 5,266,322 (-)NCBINHGRI_mPanPan1
PanPan1.1161,234,218 - 1,236,068 (-)NCBIPanPan1.1PanPan1.1panPan2
MCT7
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1340,616,642 - 40,619,148 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1

Variants

.
Variants in TPSB2
36 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3 copy number gain See cases [RCV000052367] Chr16:23141..11296695 [GRCh38]
Chr16:73141..11390552 [GRCh37]
Chr16:13141..11298053 [NCBI36]
Chr16:16p13.3-13.13
pathogenic
GRCh38/hg38 16p13.3(chr16:29941-2560460)x3 copy number gain See cases [RCV000052368] Chr16:29941..2560460 [GRCh38]
Chr16:79941..2610461 [GRCh37]
Chr16:19941..2550462 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:46566-1800860)x3 copy number gain See cases [RCV000052369] Chr16:46566..1800860 [GRCh38]
Chr16:96566..1850861 [GRCh37]
Chr16:36566..1790862 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:46766-3214623)x3 copy number gain See cases [RCV000052370] Chr16:46766..3214623 [GRCh38]
Chr16:96766..3264623 [GRCh37]
Chr16:36766..3204624 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:1221651-2233773)x3 copy number gain See cases [RCV000052373] Chr16:1221651..2233773 [GRCh38]
Chr16:1271651..2283774 [GRCh37]
Chr16:1211652..2223775 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:23141-1773349)x1 copy number loss See cases [RCV000053251] Chr16:23141..1773349 [GRCh38]
Chr16:73141..1823350 [GRCh37]
Chr16:13141..1763351 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:23141-1712523)x1 copy number loss See cases [RCV000053252] Chr16:23141..1712523 [GRCh38]
Chr16:73141..1762524 [GRCh37]
Chr16:13141..1702525 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:46766-1997582)x1 copy number loss See cases [RCV000053253] Chr16:46766..1997582 [GRCh38]
Chr16:96766..2047583 [GRCh37]
Chr16:36766..1987584 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:105429-1499893)x1 copy number loss See cases [RCV000053267] Chr16:105429..1499893 [GRCh38]
Chr16:155427..1549894 [GRCh37]
Chr16:95427..1489895 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3-13.13(chr16:46766-11525516)x3 copy number gain See cases [RCV000133780] Chr16:46766..11525516 [GRCh38]
Chr16:96766..11619372 [GRCh37]
Chr16:36766..11526873 [NCBI36]
Chr16:16p13.3-13.13
pathogenic
GRCh38/hg38 16p13.3(chr16:46766-1544014)x1 copy number loss See cases [RCV000134917] Chr16:46766..1544014 [GRCh38]
Chr16:96766..1594015 [GRCh37]
Chr16:36766..1534016 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:46766-4247185)x3 copy number gain See cases [RCV000136687] Chr16:46766..4247185 [GRCh38]
Chr16:96766..4297186 [GRCh37]
Chr16:36766..4237187 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:46722-1867327)x1 copy number loss See cases [RCV000137826] Chr16:46722..1867327 [GRCh38]
Chr16:96722..1917328 [GRCh37]
Chr16:36722..1857329 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3-13.12(chr16:43732-13326806)x3 copy number gain See cases [RCV000139166] Chr16:43732..13326806 [GRCh38]
Chr16:93732..13420663 [GRCh37]
Chr16:33732..13328164 [NCBI36]
Chr16:16p13.3-13.12
pathogenic
GRCh38/hg38 16p13.3(chr16:925267-1324901)x3 copy number gain See cases [RCV000142458] Chr16:925267..1324901 [GRCh38]
Chr16:975267..1374902 [GRCh37]
Chr16:915268..1314903 [NCBI36]
Chr16:16p13.3
likely pathogenic|uncertain significance
GRCh38/hg38 16p13.3-13.11(chr16:666662-15743104)x3 copy number gain See cases [RCV000143710] Chr16:666662..15743104 [GRCh38]
Chr16:716662..15836961 [GRCh37]
Chr16:656663..15744462 [NCBI36]
Chr16:16p13.3-13.11
pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 copy number gain See cases [RCV000203445] Chr16:102839..28327676 [GRCh37]
Chr16:16p13.3-11.2
pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3 copy number gain Breast ductal adenocarcinoma [RCV000207053] Chr16:1279324..31926800 [GRCh37]
Chr16:16p13.3-11.2
uncertain significance
GRCh37/hg19 16p13.3-12.3(chr16:1274615-19073133)x3 copy number gain Breast ductal adenocarcinoma [RCV000207326] Chr16:1274615..19073133 [GRCh37]
Chr16:16p13.3-12.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:88165-1715454)x1 copy number loss See cases [RCV000239415] Chr16:88165..1715454 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:72769-1511716)x1 copy number loss See cases [RCV000240294] Chr16:72769..1511716 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1278591-1306880)x3 copy number gain See cases [RCV000447023] Chr16:1278591..1306880 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 copy number gain See cases [RCV000446684] Chr16:69193..90274381 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:78801-9169448) copy number gain See cases [RCV000446555] Chr16:78801..9169448 [GRCh37]
Chr16:16p13.3-13.2
pathogenic
GRCh37/hg19 16p13.3(chr16:97133-5122974)x3 copy number gain See cases [RCV000445663] Chr16:97133..5122974 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1278591-1306279)x3 copy number gain See cases [RCV000447716] Chr16:1278591..1306279 [GRCh37]
Chr16:16p13.3
benign
NC_000016.9:g.(?_1239945)_(1300070_?)del deletion Schizophrenia [RCV000416764] Chr16:1239945..1300070 [GRCh37]
Chr16:1179946..1240071 [NCBI36]
Chr16:16p13.3
likely pathogenic
GRCh37/hg19 16p13.3(chr16:1279620-1306279)x3 copy number gain See cases [RCV000448751] Chr16:1279620..1306279 [GRCh37]
Chr16:16p13.3
benign|likely benign
NM_024164.6(TPSB2):c.68G>T (p.Gly23Val) single nucleotide variant not provided [RCV004715233]|not specified [RCV000454387] Chr16:1229731 [GRCh38]
Chr16:1279732 [GRCh37]
Chr16:16p13.3
benign
NM_024164.6(TPSB2):c.226G>C (p.Val76Leu) single nucleotide variant not provided [RCV004715232]|not specified [RCV000455495] Chr16:1229573 [GRCh38]
Chr16:1279574 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:643377-3125125)x3 copy number gain See cases [RCV000510815] Chr16:643377..3125125 [GRCh37]
Chr16:16p13.3
uncertain significance
maternal UPD(16p) complex Hemimegalencephaly [RCV000494707] Chr16:1280042..33710558 [GRCh37]
Chr16:16p13.3-11.2
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) copy number gain See cases [RCV000511296] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 copy number gain See cases [RCV000511360] Chr16:85880..22442007 [GRCh37]
Chr16:16p13.3-12.2
pathogenic
NM_024164.6(TPSB2):c.130T>C (p.Trp44Arg) single nucleotide variant not specified [RCV004327205] Chr16:1229669 [GRCh38]
Chr16:1279670 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 copy number gain See cases [RCV000512138] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:85880-9883129)x3 copy number gain See cases [RCV000510698] Chr16:85880..9883129 [GRCh37]
Chr16:16p13.3-13.2
pathogenic
NM_024164.6(TPSB2):c.172T>A (p.Phe58Ile) single nucleotide variant not specified [RCV004317193] Chr16:1229627 [GRCh38]
Chr16:1279628 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3-12.3(chr16:85880-19806921)x3 copy number gain See cases [RCV000512194] Chr16:85880..19806921 [GRCh37]
Chr16:16p13.3-12.3
pathogenic
GRCh37/hg19 16p13.3(chr16:85880-1875694)x1 copy number loss not provided [RCV000683741] Chr16:85880..1875694 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:85880-3216551)x3 copy number gain not provided [RCV000683742] Chr16:85880..3216551 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:85880-1498731)x1 copy number loss not provided [RCV000683740] Chr16:85880..1498731 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3-13.13(chr16:85880-11209288)x3 copy number gain not provided [RCV000683743] Chr16:85880..11209288 [GRCh37]
Chr16:16p13.3-13.13
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 copy number gain not provided [RCV000738917] Chr16:88165..90163275 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 copy number gain not provided [RCV000738918] Chr16:88165..90274695 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 copy number gain not provided [RCV000738915] Chr16:61451..90294632 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1261282-1288881)x3 copy number gain not provided [RCV000751500] Chr16:1261282..1288881 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:61451-1593645)x1 copy number loss not provided [RCV000751445] Chr16:61451..1593645 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_624055)_(2550979_?)dup duplication Idiopathic generalized epilepsy [RCV001033790] Chr16:624055..2550979 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:109978-4316797) copy number gain Chromosome 16p13.3 duplication syndrome [RCV000767731] Chr16:109978..4316797 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_624055)_(2115656_?)del deletion Tuberous sclerosis 2 [RCV000811345] Chr16:624055..2115656 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1134638-1295079)x4 copy number gain not provided [RCV000848315] Chr16:1134638..1295079 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-2053328)x1 copy number loss not provided [RCV000849039] Chr16:85880..2053328 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:85880-1468459)x1 copy number loss not provided [RCV000848130] Chr16:85880..1468459 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_624055)_(2148005_?)del deletion Tuberous sclerosis 2 [RCV001033183] Chr16:624055..2148005 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_1203718)_(2185710_?)del deletion Tuberous sclerosis 2 [RCV001033886] Chr16:1203718..2185710 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:84485-5251013)x3 copy number gain not provided [RCV001537890] Chr16:84485..5251013 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:85880-5249457)x3 copy number gain not provided [RCV001259749] Chr16:85880..5249457 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1233996-1509217)x3 copy number gain not provided [RCV001259760] Chr16:1233996..1509217 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_624055)_(2153916_?)dup duplication Epilepsy [RCV001344085]|Idiopathic generalized epilepsy [RCV001316565] Chr16:624055..2153916 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-1468828) copy number loss not specified [RCV002052500] Chr16:85880..1468828 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_256302)_(5971108_?)dup duplication Familial Mediterranean fever [RCV001877532]|Fanconi anemia [RCV001877533]|not provided [RCV001877531] Chr16:256302..5971108 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_256302)_(4852572_?)dup duplication Epilepsy [RCV003113403]|Idiopathic generalized epilepsy [RCV003109446]|Saldino-Mainzer syndrome [RCV003113404] Chr16:256302..4852572 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_256302)_(1843653_?)del deletion Idiopathic generalized epilepsy [RCV003109815] Chr16:256302..1843653 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_256302)_(1657267_?)del deletion Saldino-Mainzer syndrome [RCV003116765]|not provided [RCV003116766] Chr16:256302..1657267 [GRCh37]
Chr16:16p13.3
pathogenic|no classifications from unflagged records
NC_000016.9:g.(?_256302)_(1918176_?)del deletion not provided [RCV003119703] Chr16:256302..1918176 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:111043-6627459)x3 copy number gain See cases [RCV002292215] Chr16:111043..6627459 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1129080-2021055)x3 copy number gain not provided [RCV002473769] Chr16:1129080..2021055 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:85881-1350186)x1 copy number loss not provided [RCV002474576] Chr16:85881..1350186 [GRCh37]
Chr16:16p13.3
pathogenic
NM_024164.6(TPSB2):c.376G>C (p.Glu126Gln) single nucleotide variant not specified [RCV004188775] Chr16:1229314 [GRCh38]
Chr16:1279315 [GRCh37]
Chr16:16p13.3
likely benign
NM_024164.6(TPSB2):c.397G>A (p.Val133Ile) single nucleotide variant not specified [RCV004246523] Chr16:1229293 [GRCh38]
Chr16:1279294 [GRCh37]
Chr16:16p13.3
likely benign
NM_024164.6(TPSB2):c.151C>T (p.Arg51Cys) single nucleotide variant not specified [RCV004145600] Chr16:1229648 [GRCh38]
Chr16:1279649 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.64C>A (p.Pro22Thr) single nucleotide variant not specified [RCV004198527] Chr16:1229735 [GRCh38]
Chr16:1279736 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.367G>A (p.Ala123Thr) single nucleotide variant not specified [RCV004198733] Chr16:1229323 [GRCh38]
Chr16:1279324 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.23C>A (p.Ala8Glu) single nucleotide variant not specified [RCV004168932] Chr16:1229929 [GRCh38]
Chr16:1279930 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.261G>C (p.Arg87Ser) single nucleotide variant not provided [RCV004809934]|not specified [RCV004173940] Chr16:1229429 [GRCh38]
Chr16:1279430 [GRCh37]
Chr16:16p13.3
likely benign|uncertain significance
NM_024164.6(TPSB2):c.247C>G (p.Leu83Val) single nucleotide variant not specified [RCV004147301] Chr16:1229443 [GRCh38]
Chr16:1279444 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.38C>T (p.Ala13Val) single nucleotide variant not specified [RCV004141040] Chr16:1229914 [GRCh38]
Chr16:1279915 [GRCh37]
Chr16:16p13.3
likely benign
NM_024164.6(TPSB2):c.178G>T (p.Gly60Trp) single nucleotide variant not specified [RCV004090864] Chr16:1229621 [GRCh38]
Chr16:1279622 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:811896-2130379)x1 copy number loss not provided [RCV003222891] Chr16:811896..2130379 [GRCh37]
Chr16:16p13.3
pathogenic
NM_024164.6(TPSB2):c.41G>A (p.Ser14Asn) single nucleotide variant not specified [RCV004263369] Chr16:1229911 [GRCh38]
Chr16:1279912 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.242A>G (p.Lys81Arg) single nucleotide variant not specified [RCV004284910] Chr16:1229448 [GRCh38]
Chr16:1279449 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.666C>T (p.Gly222=) single nucleotide variant not provided [RCV003395164] Chr16:1228812 [GRCh38]
Chr16:1278812 [GRCh37]
Chr16:16p13.3
likely benign
GRCh37/hg19 16p13.3(chr16:85881-1657611)x1 copy number loss not provided [RCV003483253] Chr16:85881..1657611 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:898328-1349091)x3 copy number gain not provided [RCV003485079] Chr16:898328..1349091 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:1054247-2592737)x3 copy number gain not provided [RCV003485080] Chr16:1054247..2592737 [GRCh37]
Chr16:16p13.3
likely pathogenic
NM_024164.6(TPSB2):c.716C>T (p.Ala239Val) single nucleotide variant not provided [RCV003390601] Chr16:1228762 [GRCh38]
Chr16:1278762 [GRCh37]
Chr16:16p13.3
likely benign
NM_024164.6(TPSB2):c.255C>T (p.Ala85=) single nucleotide variant not provided [RCV003395165] Chr16:1229435 [GRCh38]
Chr16:1279436 [GRCh37]
Chr16:16p13.3
likely benign
GRCh37/hg19 16p13.3(chr16:1252411-1297707)x1 copy number loss not specified [RCV003987194] Chr16:1252411..1297707 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.325G>A (p.Val109Met) single nucleotide variant not specified [RCV004471006] Chr16:1229365 [GRCh38]
Chr16:1279366 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.359C>T (p.Ala120Val) single nucleotide variant not specified [RCV004471007] Chr16:1229331 [GRCh38]
Chr16:1279332 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.31G>A (p.Val11Ile) single nucleotide variant not specified [RCV004471005] Chr16:1229921 [GRCh38]
Chr16:1279922 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.43C>T (p.Arg15Cys) single nucleotide variant not specified [RCV004471008] Chr16:1229909 [GRCh38]
Chr16:1279910 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_256302)_(1557737_?)del deletion not provided [RCV004582850] Chr16:256302..1557737 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_339420)_(3767509_?)dup duplication Epilepsy [RCV004581460]|Idiopathic generalized epilepsy [RCV004581461] Chr16:339420..3767509 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.718G>A (p.Gly240Ser) single nucleotide variant not specified [RCV004677355] Chr16:1228760 [GRCh38]
Chr16:1278760 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3-13.13(chr16:85881-12268399)x3 copy number gain not provided [RCV004819312] Chr16:85881..12268399 [GRCh37]
Chr16:16p13.3-13.13
pathogenic
GRCh37/hg19 16p13.3(chr16:513767-5555136)x3 copy number gain not provided [RCV004819313] Chr16:513767..5555136 [GRCh37]
Chr16:16p13.3
pathogenic
NM_024164.6(TPSB2):c.225C>G (p.Cys75Trp) single nucleotide variant not specified [RCV004878263] Chr16:1229574 [GRCh38]
Chr16:1279575 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.62C>T (p.Ala21Val) single nucleotide variant not specified [RCV004878264] Chr16:1229737 [GRCh38]
Chr16:1279738 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.308C>G (p.Pro103Arg) single nucleotide variant not specified [RCV004878265] Chr16:1229382 [GRCh38]
Chr16:1279383 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.350A>T (p.Gln117Leu) single nucleotide variant not specified [RCV004878266] Chr16:1229340 [GRCh38]
Chr16:1279341 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.230G>A (p.Gly77Glu) single nucleotide variant not specified [RCV004878267] Chr16:1229569 [GRCh38]
Chr16:1279570 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.293A>G (p.Gln98Arg) single nucleotide variant not specified [RCV004878268] Chr16:1229397 [GRCh38]
Chr16:1279398 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.445T>C (p.Phe149Leu) single nucleotide variant not specified [RCV005290141] Chr16:1229245 [GRCh38]
Chr16:1279246 [GRCh37]
Chr16:16p13.3
uncertain significance
NM_024164.6(TPSB2):c.72G>A (p.Gln24=) single nucleotide variant not provided [RCV005426859] Chr16:1229727 [GRCh38]
Chr16:1279728 [GRCh37]
Chr16:16p13.3
likely benign
miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:1401
Count of miRNA genes:691
Interacting mature miRNAs:801
Transcripts:ENST00000339687, ENST00000430512, ENST00000445910, ENST00000606293
Prediction methods:Microtar, Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCh38)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
597300859GWAS1396933_Htryptase beta-2 measurement QTL GWAS1396933 (human)6e-250tryptase beta-2 measurement1612292671229268Human
597300862GWAS1396936_Htryptase beta-2 measurement QTL GWAS1396936 (human)2e-313tryptase beta-2 measurement1612298151229816Human
597485017GWAS1581091_Hurticaria QTL GWAS1581091 (human)1e-08urticaria1612300861230087Human
597346172GWAS1442246_Hbasophil measurement QTL GWAS1442246 (human)3e-10basophil measurement1612286151228616Human
406892808GWAS541784_Htryptase beta-2 measurement QTL GWAS541784 (human)6e-250tryptase beta-2 measurement1612292671229268Human
628808178GWAS2716407_Hprotein measurement QTL GWAS2716407 (human)1e-09protein amount (VT:0010120)1612298151229816Human
406892810GWAS541786_Htryptase beta-2 measurement QTL GWAS541786 (human)2e-313tryptase beta-2 measurement1612298151229816Human
628605533GWAS2513762_Hurticaria QTL GWAS2513762 (human)1e-08urticaria1612300861230087Human
407279434GWAS928410_Hurticaria QTL GWAS928410 (human)1e-08urticaria1612300861230087Human
597176854GWAS1272928_Hprotein measurement QTL GWAS1272928 (human)1e-09protein measurement1612298151229816Human
406955150GWAS604126_Htryptase beta-2 measurement QTL GWAS604126 (human)4e-2075tryptase beta-2 measurement1612300861230087Human
628579175GWAS2487404_Htryptase beta-2 measurement QTL GWAS2487404 (human)6e-250tryptase beta-2 measurement1612292671229268Human
628659948GWAS2568177_Hbasophil measurement QTL GWAS2568177 (human)3e-10basophil morphology trait (VT:0002422)1612286151228616Human
628806764GWAS2714993_Htryptase beta-2 measurement QTL GWAS2714993 (human)4e-2075tryptase beta-2 measurement1612300861230087Human
407167007GWAS815983_Hbasophil measurement QTL GWAS815983 (human)3e-10basophil measurement1612286151228616Human
406959258GWAS608234_Hprotein measurement QTL GWAS608234 (human)1e-09protein measurement1612298151229816Human
597497089GWAS1593163_Htryptase beta-2 measurement QTL GWAS1593163 (human)4e-2075tryptase beta-2 measurement1612300861230087Human
628579178GWAS2487407_Htryptase beta-2 measurement QTL GWAS2487407 (human)2e-313tryptase beta-2 measurement1612298151229816Human

Markers in Region
RH80805  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37161,292,287 - 1,292,534UniSTSGRCh37
Build 36161,232,288 - 1,232,535RGDNCBI36
Celera161,494,250 - 1,494,497RGD
Cytogenetic Map16p13.3UniSTS
HuRef161,211,415 - 1,211,662UniSTS
HuRef161,223,075 - 1,223,322UniSTS
GeneMap99-GB4 RH Map1645.24UniSTS
RH78261  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37161,292,377 - 1,292,521UniSTSGRCh37
GRCh37161,278,370 - 1,278,514UniSTSGRCh37
Build 36161,218,371 - 1,218,515RGDNCBI36
Celera161,494,263 - 1,494,407RGD
Cytogenetic Map16p13.3UniSTS
HuRef161,211,428 - 1,211,572UniSTS
HuRef161,223,088 - 1,223,232UniSTS
GeneMap99-GB4 RH Map1630.02UniSTS
RH78935  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37161,292,538 - 1,292,668UniSTSGRCh37
GRCh37161,278,223 - 1,278,353UniSTSGRCh37
Build 36161,218,224 - 1,218,354RGDNCBI36
Celera161,494,116 - 1,494,246RGD
Cytogenetic Map16p13.3UniSTS
HuRef161,211,281 - 1,211,411UniSTS
HuRef161,222,941 - 1,223,071UniSTS
GeneMap99-GB4 RH Map1630.02UniSTS
RH69115  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37161,292,311 - 1,292,459UniSTSGRCh37
GRCh37161,278,432 - 1,278,580UniSTSGRCh37
Build 36161,218,433 - 1,218,581RGDNCBI36
Celera161,494,325 - 1,494,473RGD
Cytogenetic Map16p13.3UniSTS
HuRef161,211,490 - 1,211,638UniSTS
HuRef161,223,150 - 1,223,298UniSTS
GeneMap99-GB4 RH Map1638.83UniSTS


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
entire extraembryonic component
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
1204 2371 2785 2228 4742 1687 2209 3 608 1428 449 2198 6656 5925 33 3574 796 1658 1493 165

Sequence

Nucleotide Sequences
RefSeq Transcripts NG_032951 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_024164 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NR_178183 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AC120498 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AE006466 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF099143 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AH007463 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK308208 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AMYH02031223 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC028059 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC029356 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CP068262 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  FJ931119 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  FJ931120 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  HM005476 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M33492 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M33493 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  S55551 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Ensembl Acc Id: ENST00000606293   ⟹   ENSP00000482743
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,336 - 1,230,184 (-)Ensembl
Ensembl Acc Id: ENST00000611196   ⟹   ENSP00000484461
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,227,272 - 1,230,184 (-)Ensembl
Ensembl Acc Id: ENST00000612142   ⟹   ENSP00000478695
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,336 - 1,230,166 (-)Ensembl
Ensembl Acc Id: ENST00000711420
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,335 - 1,232,757 (-)Ensembl
Ensembl Acc Id: ENST00000711421   ⟹   ENSP00000518738
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,336 - 1,230,184 (-)Ensembl
Ensembl Acc Id: ENST00000905921   ⟹   ENSP00000575980
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,336 - 1,230,124 (-)Ensembl
Ensembl Acc Id: ENST00000905922   ⟹   ENSP00000575981
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,337 - 1,230,120 (-)Ensembl
Ensembl Acc Id: ENST00000905923   ⟹   ENSP00000575982
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,338 - 1,229,951 (-)Ensembl
Ensembl Acc Id: ENST00000955802   ⟹   ENSP00000625861
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,336 - 1,233,725 (-)Ensembl
Ensembl Acc Id: ENST00000955803   ⟹   ENSP00000625862
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl161,228,336 - 1,230,184 (-)Ensembl
RefSeq Acc Id: NM_024164   ⟹   NP_077078
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38161,228,336 - 1,230,184 (-)NCBI
GRCh37161,278,336 - 1,280,185 (-)ENTREZGENE
Build 36161,218,337 - 1,220,186 (-)NCBI Archive
HuRef161,211,394 - 1,224,892 (-)ENTREZGENE
CHM1_1161,278,009 - 1,279,872 (-)NCBI
T2T-CHM13v2.0161,243,646 - 1,245,495 (-)NCBI
Sequence:
RefSeq Acc Id: NR_178183
RefSeq Status: REVIEWED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0161,243,646 - 1,245,495 (-)NCBI
RefSeq Acc Id: NP_077078   ⟸   NM_024164
- Peptide Label: preproprotein
- UniProtKB: Q9UQI7 (UniProtKB/Swiss-Prot),   Q9UQI6 (UniProtKB/Swiss-Prot),   Q15664 (UniProtKB/Swiss-Prot),   O95827 (UniProtKB/Swiss-Prot),   D2E6S2 (UniProtKB/Swiss-Prot),   D2E6S0 (UniProtKB/Swiss-Prot),   P20231 (UniProtKB/Swiss-Prot),   A0A140VJT7 (UniProtKB/TrEMBL),   A0A384MTT9 (UniProtKB/TrEMBL),   Q6B051 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSP00000484461   ⟸   ENST00000611196
Ensembl Acc Id: ENSP00000478695   ⟸   ENST00000612142
Ensembl Acc Id: ENSP00000482743   ⟸   ENST00000606293
Ensembl Acc Id: ENSP00000518738   ⟸   ENST00000711421
Ensembl Acc Id: ENSP00000625862   ⟸   ENST00000955803
Ensembl Acc Id: ENSP00000575980   ⟸   ENST00000905921
Ensembl Acc Id: ENSP00000625861   ⟸   ENST00000955802
Ensembl Acc Id: ENSP00000575981   ⟸   ENST00000905922
Ensembl Acc Id: ENSP00000575982   ⟸   ENST00000905923
Protein Domains
Peptidase S1

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P20231-F1-model_v2 AlphaFold P20231 1-275 view protein structure

Promoters
RGD ID:7230875
Promoter ID:EPDNEW_H21182
Type:initiation region
Name:TPSB2_1
Description:tryptase beta 2 (gene/pseudogene)
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38161,230,184 - 1,230,244EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:14120 AgrOrtholog
COSMIC TPSB2 COSMIC
Ensembl Genes ENSG00000197253 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000606293 ENTREZGENE
  ENST00000606293.5 UniProtKB/Swiss-Prot
Gene3D-CATH 2.40.10.10 UniProtKB/Swiss-Prot
GTEx ENSG00000197253 GTEx
HGNC ID HGNC:14120 ENTREZGENE
Human Proteome Map TPSB2 Human Proteome Map
InterPro Peptidase_S1_PA UniProtKB/Swiss-Prot
  Peptidase_S1_PA_chymotrypsin UniProtKB/Swiss-Prot
  Peptidase_S1A UniProtKB/Swiss-Prot
  Trypsin_dom UniProtKB/Swiss-Prot
  TRYPSIN_HIS UniProtKB/Swiss-Prot
  TRYPSIN_SER UniProtKB/Swiss-Prot
KEGG Report hsa:64499 UniProtKB/Swiss-Prot
NCBI Gene 64499 ENTREZGENE
OMIM 191081 OMIM
PANTHER CHYMOTRYPSIN-LIKE PROTEASE CTRL-1-RELATED UniProtKB/Swiss-Prot
  TRANSMEMBRANE PROTEASE SERINE UniProtKB/Swiss-Prot
Pfam Trypsin UniProtKB/Swiss-Prot
PharmGKB PA37846 PharmGKB
PRINTS CHYMOTRYPSIN UniProtKB/Swiss-Prot
PROSITE TRYPSIN_DOM UniProtKB/Swiss-Prot
  TRYPSIN_HIS UniProtKB/Swiss-Prot
  TRYPSIN_SER UniProtKB/Swiss-Prot
SMART Tryp_SPc UniProtKB/Swiss-Prot
Superfamily-SCOP SSF50494 UniProtKB/Swiss-Prot
UniProt A0A087WUI4_HUMAN UniProtKB/TrEMBL
  A0A087X1U0_HUMAN UniProtKB/TrEMBL
  A0A140VJT7 ENTREZGENE, UniProtKB/TrEMBL
  A0A384MTT9 ENTREZGENE, UniProtKB/TrEMBL
  A0AAA9YHG7_HUMAN UniProtKB/TrEMBL
  D2E6S0 ENTREZGENE
  D2E6S2 ENTREZGENE
  O95827 ENTREZGENE
  P20231 ENTREZGENE
  Q15664 ENTREZGENE
  Q6B051 ENTREZGENE, UniProtKB/TrEMBL
  Q6FHB8_HUMAN UniProtKB/TrEMBL
  Q6NZY1_HUMAN UniProtKB/TrEMBL
  Q9UQI6 ENTREZGENE
  Q9UQI7 ENTREZGENE
  TRYB2_HUMAN UniProtKB/Swiss-Prot
UniProt Secondary D2E6S0 UniProtKB/Swiss-Prot
  D2E6S2 UniProtKB/Swiss-Prot
  O95827 UniProtKB/Swiss-Prot
  Q15664 UniProtKB/Swiss-Prot
  Q9UQI6 UniProtKB/Swiss-Prot
  Q9UQI7 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2020-05-11 TPSB2  tryptase beta 2  TPSB2  tryptase beta 2 (gene/pseudogene)  Symbol and/or name change 19259463 PROVISIONAL
2011-07-27 TPSB2  tryptase beta 2 (gene/pseudogene)  TPSB2  tryptase beta 2  Symbol and/or name change 5135510 APPROVED